The Sleep, Cancer and Rest (SleepCare) Trial: A Randomised, Controlled Trial of Four Treatments for Sleep during Chemotherapy

Not Applicable

Recruiting

• Conditions: poor sleep; breast cancer; Cancer - Breast

• Registration Number: ACTRN12620001133921
• Lead Sponsor: Monash University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-10-30
• Last Update Posted: 4 April 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 210

Inclusion Criteria

(a)Breast cancer diagnosis;
(b)Age greater than or equal to 18 years;
(c)Receiving oral or intravenous cytotoxic chemotherapy, with at least 6 weeks of chemotherapy treatment anticipated at the time of enrolment;
(d)Able to read and write in English;
(e)Able to provide informed consent;
(f)Have regular access to email and internet.

Exclusion Criteria

(a)History of suffering migraines;
(b)Severe psychiatric disorder including substance use disorders;
(c)Male;
(d)Daily use of sleep medications or herbal sleep aids for the previous two weeks or ongoing/planned daily use during the trial;
(e)Brain metastasis with daily steroid use;
(f)Significant symptoms of the following sleep disorders based on The Structured Clinical Interview for Sleep Disorders (SCISD-R; Taylor, Kelly, Kohut, & Song, 2017): narcolepsy, sleep apnoea, periodic limb movement disorder, restless legs syndrome, circadian rhythm sleep disorders.

Study & Design

• Study Type: Interventional
• Study Design: Not specified